On May 14, Corcept Therapeutics Incorporated (NASDAQ:CORT) Director Joseph Cook, Jr. purchased 100,000 shares of the company’s stock on the open market in a transaction dated Tuesday, May 13th. The shares were purchased at an average price of $1.84 per share, with a total value of $184,000.00. Following the purchase, the director now directly owns 2,040,826 shares in the company, valued at approximately $3,755,120. Corcept Therapeutics Incorporated (NASDAQ:CORT) weekly performance is 14.95%. On last trading day company shares ended up $2.23. Analysts mean target price for the company is $2.80. Corcept Therapeutics Incorporated (NASDAQ:CORT) distance from 50-day simple moving average (SMA50) is -34.83%.
PTC Therapeutics, Inc. (NASDAQ:PTCT)’s shares surged 30.74% to $20.03. The company on May 23 announced that following its request for re-examination, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the company’s application for a conditional marketing authorization of TranslarnaTM (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged five years and older. PTC Therapeutics, Inc. (NASDAQ:PTCT) shares advanced 15.06% in last trading session and ended the day on $24.37. Its return on assets is -27.20%. PTC Therapeutics, Inc. (NASDAQ:PTCT) quarterly performance is -24.67%.
On May 14, Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) reported first quarter 2014 loss (excluding the change in fair value of financial instruments) of 18 cents per share, narrower than the year-ago loss and the Zacks Consensus Estimate of a loss of 24 cents. Research and development expenses at Synergy Pharma declined 7.3% to $13.3 million in the first quarter of 2014. General and administrative costs in the reported quarter remained flat at $3.2 million. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares moved up 6.99% in last trading session and was closed at $4.44, while trading in range of $4.18 – $4.47. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) year to date (YTD) performance is -20.00%.
Synaptics Incorporated (NASDAQ:SYNA) the leading developer of human interface solutions, announced that Huawei has once again selected the ClearPad®family of capacitive touchscreen solutions to power the touch interface of its latest flagship smartphone device, the Ascend P7. By leveraging the ClearPad S3350 In-Cell solution, Huawei is able to offer Ascend P7 users glove input, passive pen and moisture-proofing support, while providing seamless touch performance on the first 5-inch full high-definition (FHD) In-Cell touchscreen device from the Chinese market. This design win further highlights Synaptics’ strong relationship with leading Chinese OEMs, like Huawei, who have a global market presence and growing customer base. Synaptics, Incorporated (NASDAQ:SYNA) ended the last trading day at $67.78. Company weekly volatility is calculated as 5.20% and price to cash ratio as 6.24. Synaptics, Incorporated (NASDAQ:SYNA) showed a positive weekly performance of 17.39%.
On May 21, MagneGas Corporation (NASDAQ:MNGA) a technology company that counts among its inventions a patented process that converts liquid waste into a hydrogen-based fuel, solutions and services, announced that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel. MagneGas Corporation (NASDAQ:MNGA) weekly performance is 32.54%. On last trading day company shares ended up $1.67. Analysts mean target price for the company is $0.95. MagneGas Corporation (NASDAQ:MNGA) distance from 50-day simple moving average (SMA50) is 18.71%.